US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Curanex Pharmaceuticals

1.25

-0.2650-17.49%

Post-market: 1.24-0.0102-0.82%18:55 EDT

Volume:9.26M

Turnover:11.57M

Market Cap:34.69M

PE:-57.03

High:1.35

Open:1.35

Low:1.11

Close:1.52

52wk High:9.18

52wk Low:1.11

Shares:27.75M

Float Shares:9.09M

Volume Ratio:1.27

T/O Rate:101.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0219

EPS(LYR):-0.0273

ROE:-85.25%

ROA:-30.03%

PB:113.61

PE(LYR):-45.85

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Curanex Pharmaceuticals Inc trading halted, volatility trading pause

Curanex Pharmaceuticals Boosts IPO Proceeds with Share Sale

Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters

Curanex Pharmaceuticals Reports No Revenue for Q2 2025, General and Administrative Expenses Rise 30% from Q2 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CURX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","market":"US","secType":"STK","nameCN":"Curanex Pharmaceuticals","latestPrice":1.25,"timestamp":1758225600000,"preClose":1.515,"halted":0,"volume":9258697,"hourTrading":{"tag":"盘后","latestPrice":1.2398,"preClose":1.25,"latestTime":"18:55 EDT","volume":49833,"amount":62089.5459492,"timestamp":1758236108357},"delay":0,"floatShares":9093100,"shares":27750000,"eps":-0.02192,"marketStatus":"Post-Mkt","change":-0.265,"latestTime":"09-18 18:56:43 EDT","open":1.35,"high":1.35,"low":1.11,"amount":11572225.9491811,"amplitude":0.158416,"askPrice":1.32,"askSize":531,"bidPrice":1.22,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.02192,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1758240000000},"marketStatusCode":4,"adr":0,"listingDate":1756180800000,"exchange":"NASDAQ","adjPreClose":1.515,"preHourTrading":{"tag":"盘前","latestPrice":1.35,"preClose":1.515,"latestTime":"09:29 EDT","volume":437838,"amount":608694.3843611999,"timestamp":1758202199999},"postHourTrading":{"tag":"盘后","latestPrice":1.2398,"preClose":1.25,"latestTime":"18:55 EDT","volume":49833,"amount":62089.5459492,"timestamp":1758236108357},"volumeRatio":1.272993},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","floatShares":9093100,"roa":"-30.03%","roe":"-85.25%","lyrEps":-0.027264,"volumeRatio":1.272993,"shares":27750000,"dividePrice":0,"high":1.35,"amplitude":0.158416,"preClose":1.515,"low":1.11,"week52Low":1.11,"pbRate":"113.61","week52High":9.1796,"institutionHeld":0,"latestPrice":1.25,"committee":-0.683043,"eps":-0.02192,"divideRate":0,"volume":9258697,"delay":0,"ttmEps":-0.02192,"open":1.35,"prevYearClose":4,"prevWeekClose":8.595,"prevMonthClose":5.6,"prevQuarterClose":4,"fiveDayClose":8.19,"twentyDayClose":4,"sixtyDayClose":4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CURX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CURX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CURX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CURX","date":"2025-09-17","current":-596.14306,"percent":0,"low":-596.14306,"twenty":-527.666516,"median":-470.352457,"eighty":-337.125914,"high":-249.517771,"avg":-436.688019,"sd":101.631296,"marketCap":259342500},"quantilePoints":[{"date":"2025-08-29","current":-343.821021,"twenty":-323.7357,"median":-309.527845,"eighty":-285.033231,"marketCap":144022500},{"date":"2025-09-05","current":-470.352457,"twenty":-397.745937,"median":-357.40162,"eighty":-309.364317,"marketCap":197025000},{"date":"2025-09-12","current":-522.424684,"twenty":-490.623986,"median":-396.156013,"eighty":-317.040593,"marketCap":227272500},{"date":"2025-09-17","current":-596.14306,"twenty":-527.666516,"median":-470.352457,"eighty":-337.125914,"marketCap":259342500}],"updateTime":1758236203945},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CURX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568902644","title":"Curanex Pharmaceuticals Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2568902644","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568902644?lang=en_us&edition=fundamental","pubTime":"2025-09-17 23:20","pubTimestamp":1758122418,"startTime":"0","endTime":"0","summary":"11:18 EDT Curanex (CURX) Pharmaceuticals Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/curanex-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/curanex-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CURX"],"gpt_icon":0},{"id":"2567909675","title":"Curanex Pharmaceuticals Boosts IPO Proceeds with Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2567909675","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567909675?lang=en_us&edition=fundamental","pubTime":"2025-09-13 03:17","pubTimestamp":1757704656,"startTime":"0","endTime":"0","summary":"An announcement from Curanex Pharmaceuticals Inc. ( ($CURX) ) is now available. On August 27, 2025, Curanex Pharmaceuticals Inc closed its initial ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curanex-pharmaceuticals-boosts-ipo-proceeds-with-share-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curanex-pharmaceuticals-boosts-ipo-proceeds-with-share-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CURX"],"gpt_icon":0},{"id":"2567783906","title":"Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters","url":"https://stock-news.laohu8.com/highlight/detail?id=2567783906","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567783906?lang=en_us&edition=fundamental","pubTime":"2025-09-13 02:46","pubTimestamp":1757702760,"startTime":"0","endTime":"0","summary":"Jericho, New York, Sept.  12, 2025  (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/12/3149402/0/en/Curanex-Pharmaceuticals-Inc-Announces-Exercise-of-the-Over-Allotment-Option-by-Underwriters.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX","BK4007"],"gpt_icon":0},{"id":"2566161062","title":"Curanex Pharmaceuticals Reports No Revenue for Q2 2025, General and Administrative Expenses Rise 30% from Q2 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2566161062","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566161062?lang=en_us&edition=fundamental","pubTime":"2025-09-10 03:29","pubTimestamp":1757446183,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. recently reported its quarterly results for the period ending June 30, 2025. The company did not generate any revenue during the three months ended June 30, 2025, which aligns with its ongoing focus on the development of botanical drug candidates and achieving clinical and regulatory milestones. Operating expenses saw an increase, with general and administrative expenses rising to $57,658 for the three months ended June 30, 2025, compared to $44,200 for the same period in 2024. This increase is attributed mainly to the ongoing costs related to the company's preparation for an initial public offering  and maintaining readiness for operating as a public company. For the six-month period ending June 30, 2025, Curanex also reported no revenue, consistent with its strategic focus. General and administrative expenses for this period increased to $195,110 from $124,401 in the same period in 2024, again primarily due to IPO-related costs. The company has stated tha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL5MC2R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CURX\",params:#limit:6,delay:false,,,undefined,":[]}}